In addition, the clinical significance of PGAM1 expression was assessed in HCC patients receiving anti‐PD‐1 immunotherapy, and higher expression of PGAM1 was found in non‐responders. This evidence concerns the gene PGAM1 and hepatocellular carcinoma.